Newest Healthtech Companies — 2026

Browse the newest privately-funded Healthtech companies. Sorted by filing date, with the most recent on top.

About Healthtech

Healthtech private companies here span digital health platforms, electronic health records, patient-engagement tools, care-delivery software, remote monitoring, and health-insurance technology. This sector excludes biotech (drug discovery and therapeutics) and medical devices, which live under Biotech and Hardware & IoT respectively. Healthtech Form D filings often stay in the $10M–$50M range for Series A and B — smaller than AI or biotech. Delaware C-corporations under Rule 506(b) are standard. The regulatory environment — HIPAA, state privacy laws, FDA software-as-medical-device classifications, CMS reimbursement coding — shapes both round sizes and investor mix. Strategic investors often include hospital systems, payers (UnitedHealth, Humana, Blue Cross), and health-focused VCs. This sector hub lists the most recent healthtech Form D filings parsed from SEC EDGAR.

In 2026, Healthtech accounts for 86 catalogued filings totaling $775M, running at roughly 18.0 filings per week over the last 30 days.

Total raised
$775M
Median offering
$2.5M
Active states
10
Last 30 days
77

Featured Healthtech companies in 2026

$173.1M

ByHeart, Inc.

New York, NY · Filed Mar 31, 2026

ByHeart, Inc. is a Healthtech company based in New York, NY. The company is a Corporation, incorporated in Delaware, with its office at 131…

$61.6M

HOPSCOTCH HEALTH HOLDINGS, LLC

CHICAGO, IL · Filed Apr 21, 2026

HOPSCOTCH HEALTH HOLDINGS, LLC is a Healthtech company based in CHICAGO, IL. The company is a Limited Liability Company, incorporated in Del…

$57.5M

Cerebral Inc.

CLAYMONT, DE · Filed Apr 1, 2026

Cerebral Inc. is a Healthtech company based in CLAYMONT, DE. The company is a Corporation, incorporated in Delaware, with its office at 2093…

About Healthtech private companies

Healthtech occupies a distinctive place in private capital because its customers — hospitals, health systems, payers, CMS — move on procurement cycles longer and more deliberative than typical enterprise software. This shapes filing patterns: longer between-rounds (24–36 months, not 18), smaller follow-ons relative to initial investment, and frequent venture-debt inclusion. HIPAA and state privacy compliance costs are pre-product costs, meaning seed rounds in healthtech tend to be larger than seed rounds in general SaaS. Federal Anti-Kickback Statute and Stark Law constraints on physician referrals influence commercial-ops structure, sometimes leading to Series A capital earmarked specifically for legal and compliance work. Filings under Rule 506(c) with general solicitation are rare in healthtech relative to fintech or real estate, where the regulatory comfort is different.

Healthtech funding trends

Recent healthtech Form D filings show emerging patterns. First, AI-powered clinical documentation tools have become a dense cluster — these typically raise $20M–$60M Series A/B as they accumulate hospital-system design partners. Second, value-based-care infrastructure (risk-bearing organizations, claims intelligence, quality-measurement platforms) attracts larger rounds tied to growth-stage adoption by CMS programs like ACO REACH and MA Star Ratings. Third, post-2024 consumer healthtech has contracted relative to prior years; filings skew toward bridge rounds with smaller offering amounts. Fourth, Medicaid-focused platforms and state-level HHS vendors appear occasionally, often with Mid-Atlantic state addresses. Founders and investors watching this hub should note that healthtech offering amounts typically lag sectors like AI and fintech by 30–50% at equivalent maturity.